Physician profile
Alex E Mari
NPI 1609976562
$11,245.88
in general payments reported to CMS, 2019-2025
51 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,445 · 2020: $1,019 · 2021: $1,794 · 2022: $1,320 · 2023: $1,223 · 2024: $1,900 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,666.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,474.75 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $1,136.80 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,026.32 | 2019-2025 | Jardiance, Tradjenta |
| Lilly USA, LLC | $784.98 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $697.25 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $658.63 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $648.57 | 2019-2023 | Xarelto |
| Pfizer INC. | $604.98 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $317.19 | 2019-2022 | |
| Exact Sciences Corporation | $265.86 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $252.97 | 2021-2025 | Rexulti |
| Astellas Pharma US INC | $221.11 | 2019-2024 | Veozah |
| Amarin Pharma, INC. | $212.22 | 2019-2021 | |
| Novo Nordisk INC | $204.21 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $199.82 | 2021-2025 | Freestyle Libre 3 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Mari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.